A research team at Academia Sinica has developed a key reagent for a pioneering rapid screening test for the COVID-19 coronavirus disease and the technology has been transferred to seven companies, one or two of which will be chosen for possible mass production, James Liao (廖俊智), president of Taiwan's most prestigious research institution, said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
U.S. could make record arms sales to Taiwan in 2026: Business group
10/20/2025 02:55 PM - Politics
KMT lawmaker sparks debate with proposal to cane scammers
10/20/2025 02:47 PM - Culture
Taiwanese novelist Yang Shuang-zi to embark on India speaking tour
10/20/2025 01:02 PM - Society
Torrential rain alerts issued for Taipei, New Taipei
10/20/2025 12:00 PM - Society
Taiwan Railway's Pingxi Line closed due to heavy rain
10/20/2025 11:41 AM